Genmab
GMAB
GMAB
270 hedge funds and large institutions have $2.23B invested in Genmab in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 105 increasing their positions, 94 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 291 → 270 (-21)
26% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 58
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
270
Holding in Top 10
1
Calls
$16M
Puts
$977K
Top Buyers
| 1 | +$110M | |
| 2 | +$73.8M | |
| 3 | +$43.3M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$34.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$33.7M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$39.6M | |
| 3 | -$18.4M | |
| 4 |
Goldman Sachs
New York
|
-$12M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.7M |
